COVID-19 Management in the Non-Hospitalized Patient: Part 2

Home
»
COVID-19
»
Product Details

You must select a location to proceed.

Yes

There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.

Adding Registration, Please wait...

You must be logged in to perform this action.

Cancel

COVID-19 Management in the Non-Hospitalized Patient: Part 2

Credit(s):

1 Contact Hour(s) of CE; 0.5 of which may be applied towards Pharmacology

Program Number:

23056086

Original Program Date:

May 10, 2023

Duration:

1 hour 2 minutes

Access:

Available until September 30, 2023

Facebook

Twitter

E-Mail

Description
Sessions
Credits
Faculty
Materials
Reviews
Dates and Locations

(2590)

Read Reviews

Category: COVID-19, [Free CE for AANP Members], Cert Exam Domain - Assessment ... (show more)

Category: COVID-19, [Free CE for AANP Members], Cert Exam Domain - Assessment, Cert Exam Domain - Diagnosis, Cert Exam Domain - Evaluation, Cert Exam Domain - Planning, Expiring Soon (show less)

Other: Assessment, Complementary, Diagnosis ...(show more)

Other: Assessment, Complementary, Diagnosis, Evaluation (Follow-up), Evidence-Based Guidelines, Infectious Disease, Planning, Treatment
(show less)

Released: 04/12/2023
Expires: 09/30/2023 (subject to change)

CE for this activity will not be available after this date.

Webinar Date and Time: 5/10/2023 from 12:30-1:30 PM CT
On-Demand Viewing Now Available!

Overview
This activity is a live webinar that features two NP experts, Dr. Ruth Carrico and Dr. Wendy Wright, discussing the current landscape of COVID-19 outpatient treatment. The recording of the live webinar will be available as an on-demand activity after the recording for those who cannot attend the live event.

Objectives

Describe the importance of prompt COVID-19 testing in both symptomatic people and asymptomatic people with recent contact with potential or confirmed COVID-19.
Review recommendations for the diagnosis and general management of non-hospitalized patients with mild or moderate COVID-19.
Prioritize outpatient COVID-19 treatments based on individualized risk assessment for individuals with COVID-19.
Review eligibility requirements for receipt of outpatient COVID-19 therapy.
Compare outpatient pharmacotherapeutic options for COVID-19, including approved and authorized agents as well as those that are on the horizon.

Speakers
Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
Ruth Carrico, PhD, DNP, APRN, FNP-C, CIC, FSHEA, FNAP, FAAN

Disclosure
This program was planned in accordance with AANP CE Standards and Policies.

Speaker Disclosures

Ruth Carrico has the following disclosures:
- Advisory Boards—Sanofi-Pasteur, Pfizer, Janssen/Johnson & Johnson, Moderna
- Research—Sanofi-Pasteur, Pfizer, Janssen/Johnson & Johnson
Wendy Wright has the following disclosures:
- Speaker bureau—Sanofi-Pasteur, Merck, Pfizer, Seqirus (vaccines); AbbVie, Biohaven (migraines); Idorsia (insomnia)
- Consultant—Sanofi-Pasteur, Merck, Pfizer, Moderna, Seqirus (vaccines); GlaxoSmithKline (osteoarthritis, pain); Bayer (chronic kidney disease); Idorsia (insomnia); Shield Therapeutics (iron deficiency anemia)

This CE activity is supported by AANP.

All Planners involved in this activity have no relevant financial relationships to disclose.

Supported by an educational grant from PhRMA and Merck Sharp and Dohme, LLC, a division of Merck and Co., Inc.

Disclaimer
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

CE Credit Instructions

Read this activity description, including objectives and disclosures.
Complete the Pretest associated to the activity.
Complete the educational content completely:
- Webinar Presentation: Attend the live webinar version of this activity or watch the on-demand recording when it becomes available.
  - To access your Webinar the day of the event,
    - Click the green Play button on the My CE Activities page of your account
    - When prompted, click the Open Go To Opener button and you will be brought into the Webinar if you are attending the live webinar. If you are watching the on-demand recording of the webinar, the Play button will open up the streaming video media player.
- Review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
After completing all content, click on the blue Next Steps button:
- Complete the post-test.
- Submit the evaluation to receive full AANP CE/Rx credit.

Additional Information
For questions or more information concerning this online CE opportunity contact the AANP CE Support team at CECenter@aanp.org.

1 Contact Hour(s) of CE,
0.5 of which may be applied towards Pharmacology

Purchase Options

Already Registered